[Skip to Content]
[Skip to Content Landing]
August 2, 2000

Placebo Effect in Posttraumatic Stress Disorders

Author Affiliations

Stephen J.LurieMD, PhD, Contributing EditorIndividualAuthor

JAMA. 2000;284(5):563. doi:10.1001/jama.284.5.561

To the Editor: The study by Dr Brady and colleagues1 of sertraline treatment of posttraumatic stress disorder (PTSD) is a welcome addition to the sparse literature on therapeutic options for this common condition. Moreover, their conclusion that the benefit of sertraline occurred predominantly within the first 2 to 4 weeks of treatment may have important clinical implications.